Private Advisor Group’s Epizyme, Inc EPZM Stock Holding History

Private Advisor Group’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,223	Closed	-$22K	–	2200
2022 Q2	$22K	Buy	+15,223	New	+$11.2K	﹤0.01%	2073

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Private Advisor Group's EPZM Position: Q3 2022 in Review

Private Advisor Group sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 15,223 shares — an estimated $22K sold.

Private Advisor Group first reported a position in EPZM in Q2 2022 and held it in 1 quarter. The position peaked at $22K in Q2 2022. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Private Advisor Group reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Private Advisor Group sold 15,223 Epizyme, Inc shares in Q3 2022, an estimated $22K.
Private Advisor Group first reported a position in Epizyme, Inc in Q2 2022 and held it in 1 quarter.
Private Advisor Group's Epizyme, Inc position peaked at $22K in Q2 2022.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Private Advisor Group's 13F filing for Q3 2022, filed 14 Oct 2022.